BrainPath Tubular Retractor System for Subcortical Hemorrhagic Vascular Lesions: A Case Series of Technique and Outcomes.

Neurosurgery practice Pub Date : 2024-09-26 eCollection Date: 2024-12-01 DOI:10.1227/neuprac.0000000000000114
Leonard H Verhey, Andres Restrepo Orozco, Mohamed Abouelleil, Paul Mazaris, Casey J Madura, Michael Bercu, Justin A Singer
{"title":"BrainPath Tubular Retractor System for Subcortical Hemorrhagic Vascular Lesions: A Case Series of Technique and Outcomes.","authors":"Leonard H Verhey, Andres Restrepo Orozco, Mohamed Abouelleil, Paul Mazaris, Casey J Madura, Michael Bercu, Justin A Singer","doi":"10.1227/neuprac.0000000000000114","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Hemorrhagic subcortical vascular lesions such as cavernous malformations (CM) and arteriovenous malformations (AVM) can be neurologically devastating. Conventional open surgical resection is often associated with additional morbidity. The BrainPath® (NICO Corp.) transsulcal tubular retractor system offers a less-invasive corridor to deep-seated lesions. Our objective was to describe a single-center experience with the resection of subcortical hemorrhagic vascular lesions in adult and pediatric patients using the BrainPath® system.</p><p><strong>Methods: </strong>The departmental database was queried for patients who underwent resection of a hemorrhagic CM, AVM, or cerebral aneurysm through the BrainPath® tubular retractor system between January 2017 and September 2021. All patients underwent either postoperative MRI (for patients with CM) or digital subtraction angiography (for patients with AVM or aneurysm). Demographic and clinical characteristics, preoperative and postoperative imaging features, operative details, and surgical and clinical outcomes were extracted through a retrospective review of the medical records.</p><p><strong>Results: </strong>Fourteen patients (mean [SD] age 32.3 [23.9] years; 7 (50%) female) underwent BrainPath®-based resection of a deeply seated CM (n = 7), AVM (n = 6), or ruptured cerebral aneurysm (n = 1). The mean maximal lesion diameter was 21.5 (12.6) mm. The mean operative time was 134 (53) minutes. Residual lesion was present in 2 patients, both of which underwent repeat BrainPath®-assisted surgery for complete resection. All lesions were completely resected or obliterated on postoperative MRI or digital subtraction angiography. At a mean follow-up of 4.1 (1.1) years, the median modified Rankin Scale score was 1 (range 0-6).</p><p><strong>Conclusion: </strong>In a well-selected cohort, we show the effective use of BrainPath® tubular retractors for resection or obliteration of subcortical hemorrhagic vascular lesions. This report further exemplifies the expanded role of the endoport system beyond that of intracerebral hemorrhage and tumor. Further study will elucidate the impact of this less-invasive brain retraction technique on clinical outcome in patients with vascular lesions.</p>","PeriodicalId":74298,"journal":{"name":"Neurosurgery practice","volume":"5 4","pages":"e00114"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11810000/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosurgery practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1227/neuprac.0000000000000114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Hemorrhagic subcortical vascular lesions such as cavernous malformations (CM) and arteriovenous malformations (AVM) can be neurologically devastating. Conventional open surgical resection is often associated with additional morbidity. The BrainPath® (NICO Corp.) transsulcal tubular retractor system offers a less-invasive corridor to deep-seated lesions. Our objective was to describe a single-center experience with the resection of subcortical hemorrhagic vascular lesions in adult and pediatric patients using the BrainPath® system.

Methods: The departmental database was queried for patients who underwent resection of a hemorrhagic CM, AVM, or cerebral aneurysm through the BrainPath® tubular retractor system between January 2017 and September 2021. All patients underwent either postoperative MRI (for patients with CM) or digital subtraction angiography (for patients with AVM or aneurysm). Demographic and clinical characteristics, preoperative and postoperative imaging features, operative details, and surgical and clinical outcomes were extracted through a retrospective review of the medical records.

Results: Fourteen patients (mean [SD] age 32.3 [23.9] years; 7 (50%) female) underwent BrainPath®-based resection of a deeply seated CM (n = 7), AVM (n = 6), or ruptured cerebral aneurysm (n = 1). The mean maximal lesion diameter was 21.5 (12.6) mm. The mean operative time was 134 (53) minutes. Residual lesion was present in 2 patients, both of which underwent repeat BrainPath®-assisted surgery for complete resection. All lesions were completely resected or obliterated on postoperative MRI or digital subtraction angiography. At a mean follow-up of 4.1 (1.1) years, the median modified Rankin Scale score was 1 (range 0-6).

Conclusion: In a well-selected cohort, we show the effective use of BrainPath® tubular retractors for resection or obliteration of subcortical hemorrhagic vascular lesions. This report further exemplifies the expanded role of the endoport system beyond that of intracerebral hemorrhage and tumor. Further study will elucidate the impact of this less-invasive brain retraction technique on clinical outcome in patients with vascular lesions.

脑路管状牵开系统治疗皮质下出血性血管病变:技术和结果的案例系列。
背景和目的:出血性皮层下血管病变,如海绵状血管瘤(CM)和动静脉血管瘤(AVM)可对神经系统造成破坏。传统的开放手术切除常伴有额外的发病率。BrainPath®(NICO Corp.)经食管管状牵开系统为深部病变提供了侵入性较小的通道。我们的目的是描述使用BrainPath®系统切除成人和儿童皮质下出血性血管病变的单中心经验。方法:查询2017年1月至2021年9月期间通过BrainPath®管状牵开系统切除出血性CM、AVM或脑动脉瘤的患者的部门数据库。所有患者术后均行MRI (CM患者)或数字减影血管造影(AVM或动脉瘤患者)。通过对医疗记录的回顾性回顾,提取了人口统计学和临床特征、术前和术后影像学特征、手术细节以及手术和临床结果。结果:14例患者(平均[SD]年龄32.3[23.9]岁;7例(50%)女性患者接受了基于BrainPath®的深度CM (n = 7)、AVM (n = 6)或脑动脉瘤破裂(n = 1)的切除术。平均最大病变直径为21.5 (12.6)mm,平均手术时间为134(53)分钟。2例患者存在残余病变,均接受了重复的BrainPath®辅助手术以完全切除。术后MRI或数字减影血管造影显示病变完全切除或消失。在平均4.1(1.1)年的随访中,修正Rankin量表得分中位数为1(范围0-6)。结论:在一个精心挑选的队列中,我们展示了BrainPath®管状牵开器在皮质下出血性血管病变切除或闭塞中的有效应用。这一报告进一步证明了内孔系统在脑出血和肿瘤之外的扩展作用。进一步的研究将阐明这种微创脑回缩技术对血管病变患者临床结果的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信